Ignite Creation Date:
2025-12-26 @ 10:56 AM
Ignite Modification Date:
2026-01-13 @ 3:40 PM
Study NCT ID:
NCT02406508
Status:
WITHDRAWN
Last Update Posted:
2017-12-18
First Post:
2015-03-23
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Sequential Melphalan for Use With Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable HCC
Sponsor:
Delcath Systems Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2014-10
Start Date Type:
None
Primary Completion Date:
2017-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-12
Completion Date Type:
ACTUAL
First Submit Date:
2015-03-23
First Submit QC Date:
None
Study First Post Date:
2015-04-02
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2017-12-14
Last Update Post Date:
2017-12-18
Last Update Post Date Type:
ACTUAL